Merck

Pharmaceutical company that, per Zou, independently developed and validated the same antibody-drug conjugate design virtual-biotech‘s agents had produced months earlier — the design that went on to FDA breakthrough designation. It is the external party the source’s central claim rests on, and it made no statement of its own in that source. Discovered while ingesting stanford-virtual-biotech-37000-agents.

Connections

• independent validator of the therapeutic design in virtual-biotech

Related

virtual-biotech · stanford-virtual-biotech-37000-agents · james-zou